John Fruehauf
Professor Emeritus — Division of Hematology & Oncology · University of California
Credentials: · · · ·
History
- Present
- Present
- Present
- 1988–1990
Medical Oncology
- 1985–1988
Internal Medicine
- 1981–1985
Research
Reactive oxygen species: a breath of life or death?
Review · Clinical Cancer Research · 2007 · First of 2 authors · Corresponding · 709 citations
Clinical Cancer Research · 1998 · Last of 8 authors · 251 citations
Redox regulation in human melanocytes and melanoma
Review · Pigment Cell Research · 2001 · Last of 3 authors · 157 citations
- RB
11 papers
9 papers
8 papers
- PD
5 papers
- JJ
4 papers
4 papers · 4 as a fellow
3 papers · 3 as a fellow
- DA
3 papers
Grants
- 1997–2016
National Cancer Institute · P30
Project lead · $85.5K · University of California-Irvine
- 2011–2015
Novel Biologic Markers of Treatment Resistance in Locally Advanced Cervical Carci
National Cancer Institute · R21
PI · $358.7K · University of California-Irvine
- 2002–2003
Genomics Screening for Antiangiogenesis Drugs
National Cancer Institute · R43
Contact PI · $99.7K · Oncotech, Inc.
- 1993–1994
Development of an Mdr-1 Resistance-Reversal Assay
National Cancer Institute · R43
Contact PI · $50K · Oncotech, Inc.
Clinical trials
- 2011–2016
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
Principal investigator · Completed · Phase 2
University of California, Irvine
- 2010–2016
Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Naïve Prostate Cancer Patients
Principal investigator · Completed · Phase 2
University of California, Irvine
- 2010–2018
Principal investigator · Completed · Phase 2
University of California, Irvine
- 2009–2011
Principal investigator · Terminated · Phase 1, Phase 2
John P. Fruehauf